ప్రత్యేక అతిథి లానా హార్డర్‌తో పీడియాట్రిక్ న్యూరోసైకాలజీ \u0026 యాంటీ MOG అసోసియేటెడ్ డిసీజ్ (MOGAD)

(32:21)

పీడియాట్రిక్ MOGAD \u0026 NMOSD

(57:40)

Predictive and prognostic biomarkers for pediatric MOGAD and NMOSD

(3:4)

Pediatric and Adult MOGAD Diagnosis and Management From a European Perspective

(1:4:55)

808. MOG Antibody Disease: Adult and Pediatric Presentations

(54:7)

Update on pediatric NMOSD and MOGAD

(3:47)

Tanuja Chitnis, MD: Differentiating Pediatric MS From Other Demyelinating Disorders

(1:29)

207. Pediatric NMOSD | Part I

(44:53)

Research developments in MOGAD

(1:23)

702. Pediatric MOG Antibody-Associated Disease and ADEM

(55:35)

Radiological features in pediatric MOGAD - by Dr. Li-Tal Pratt

(24:11)

MOGAD: International Experts Develop Diagnostic Criteria

(57)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

(13:27)

Proposed criteria for the diagnosis of MOGAD

(1:46)

Latest in MOGAD Treatments from an Adult and Pediatric Perspective

(1:4:19)

Controversies in treating NMOSD and MOGAD

(1:54)

The pathology of MS and MOGAD: similarities and differences

(1:49)

Managing NMOSD \u0026 MOGAD Symptoms, Health, and Wellness

(53:40)

Growing up with NMOSD \u0026 MOGAD: Navigating the Pediatric Journey

(41:29)

Dr Evangeline Wassmer - Demyelinating disorders and childhood MS

(27:19)

Predicting relapses in MOGAD

(1:17)

2024 RNDS | Clinical Analysis of Children Presenting with ADEM with or without MOG-IgG

(21:11)